精品国产精品免费在线观看|亚洲一级高清在线观看|亚洲乱码尤物193yw|亚洲综合狠狠99婷婷

      Future Science Oa
      • 數(shù)據(jù)庫收錄SCIE
      • 年發(fā)文量87

      Future Science Oa

      期刊中文名:未來科學OAISSN:2056-5623

      該雜志國際簡稱:FUTUR SCI OA,是由出版商Future Science Ltd出版的一本致力于發(fā)布--研究新成果的的專業(yè)學術(shù)期刊。主要發(fā)表刊登有創(chuàng)見的學術(shù)論文文章、行業(yè)最新科研成果,扼要報道階段性研究成果和重要研究工作的最新進展,選載對學科發(fā)展起指導(dǎo)作用的綜述與專論,促進學術(shù)發(fā)展,為廣大讀者服務(wù)。該刊是一本國際優(yōu)秀雜志,在國際上有很高的學術(shù)影響力。

      基本信息:
      期刊簡稱:FUTUR SCI OA
      是否OA:開放
      是否預(yù)警:
      Gold OA文章占比:99.52%
      出版信息:
      出版地區(qū):United Kingdom
      出版語言:English
      出版商:Future Science Ltd
      評價信息:
      JCR分區(qū):Q3
      影響因子:2.4
      CiteScore:5
      雜志介紹 JCR分區(qū) CiteScore 投稿經(jīng)驗

      雜志介紹

      Future Science Oa雜志介紹

      《Future Science Oa》是一本以English為主的開放獲取國際優(yōu)秀期刊,中文名稱未來科學OA,本刊主要出版、報道領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗和科研成果,介紹該領(lǐng)域有關(guān)本專業(yè)的最新進展,探討行業(yè)發(fā)展的思路和方法,以促進學術(shù)信息交流,提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄,為該領(lǐng)域相關(guān)學科的發(fā)展起到了良好的推動作用,也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為2.4,最新CiteScore 指數(shù)為5。

      本刊近期中國學者發(fā)表的論文主要有:

      • Marketing factors associated with a continuous positive airway pressure machine purchasing in patients with obstructive sleep apnea

        Author: Sawunyavisuth, Bundit; Sopapol, Nattaporn; Tseng, Chi-Hsing; Sawanyawisuth, Kittisak

      • Identification of shared fatty acid metabolism related signatures in dilated cardiomyopathy and myocardial infarction

        Author: Huang, Baoyi; Lin, Hanying; Zhang, Qingfang; Luo, Yujun; Zhou, Biyao; Zhuo, Zewei; Sha, Weihong; Wei, Jiahui; Luo, Lihua; Zhang, Huajuan; Chen, Kequan

      • Discovery of 3CLpro inhibitor of SARS-CoV-2 main protease

        Author: Kuang, Yi; Ma, Xiaodong; Shen, Wenjing; Rao, Qingqing; Yang, Shengxiang

      英文介紹

      Future Science Oa雜志英文介紹

      Future Science Oa covers a wide range of scientific fields, including physics, chemistry, biomedicine, engineering, and mathematics. It is committed to publishing high-quality original research papers, review articles, short newsletters, and reviews, providing a platform for global researchers to exchange and share the latest scientific research achievements. The goal of the magazine is to become a global platform for scientific exchange, promote the progress of scientific research, and facilitate the popularization and application of scientific knowledge. By providing an open, transparent, and efficient environment for scientific exchange, the magazine hopes to inspire more scientific innovation, promote the development of science and technology, and make greater contributions to the well-being of humanity. As a scientific journal with the goal of promoting scientific progress, the principle of open access, and the guarantee of strict peer review. It provides a platform for scientists to share and exchange the latest scientific research results, which is of great significance for promoting the development of global science.

      JCR分區(qū)(2023-2024年最新版)

      Future Science Oa雜志 JCR分區(qū)信息

      按JIF指標學科分區(qū)
      學科:MEDICINE, RESEARCH & EXPERIMENTAL
      收錄子集:ESCI
      分區(qū):Q3
      排名:105 / 189
      百分位:

      44.7%

      按JCI指標學科分區(qū)
      學科:MEDICINE, RESEARCH & EXPERIMENTAL
      收錄子集:ESCI
      分區(qū):Q3
      排名:131 / 189
      百分位:

      30.95%

      JCR分區(qū):JCR分區(qū)來自科睿唯安公司,JCR是一個獨特的多學科期刊評價工具,為唯一提供基于引文數(shù)據(jù)的統(tǒng)計信息的期刊評價資源。每年發(fā)布的JCR分區(qū),設(shè)置了254個具體學科。JCR分區(qū)根據(jù)每個學科分類按照期刊當年的影響因子高低將期刊平均分為4個區(qū),分別為Q1、Q2、Q3和Q4,各占25%。JCR分區(qū)中期刊的數(shù)量是均勻分為四個部分的。

      CiteScore 評價數(shù)據(jù)(2024年最新版)

      Future Science Oa雜志CiteScore 評價數(shù)據(jù)

      • CiteScore 值:5
      • SJR:0.527
      • SNIP:0.657
      學科類別 分區(qū) 排名 百分位
      大類:Medicine 小類:General Medicine Q1 100 / 636

      84%

      大類:Medicine 小類:Biotechnology Q2 145 / 311

      53%

      歷年影響因子和期刊自引率

      投稿經(jīng)驗

      Future Science Oa雜志投稿經(jīng)驗

      該雜志是一本國際優(yōu)秀雜志,在國際上有較高的學術(shù)影響力,行業(yè)關(guān)注度很高,已被國際權(quán)威數(shù)據(jù)庫SCIE收錄,該雜志在綜合專業(yè)領(lǐng)域?qū)I(yè)度認可很高,對稿件內(nèi)容的創(chuàng)新性和學術(shù)性要求很高,作為一本國際優(yōu)秀雜志,一般投稿過審時間都較長,投稿過審時間平均 13 Weeks ,如果想投稿該刊要做好時間安排。版面費不祥。該雜志近兩年未被列入預(yù)警名單,建議您投稿。如您想了解更多投稿政策及投稿方案,請咨詢客服。

      免責聲明

      若用戶需要出版服務(wù),請聯(lián)系出版商。